Keywords
ConcordanceTrastuzumabBreast cancerImmunohistochemistryFluorescence in situ hybridizationImmunostainingMedicineCancerPathologyIn situ hybridizationOncologyBiologyInternal medicineGene expressionGene
Affiliated Institutions
Related Publications
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Aims: Human epidermal growth factor receptor 2 (HER2) overexpression/amplification is implicated in the development of various solid tumour types. Validated methods and scoring ...
Disease-Free Survival According to Degree of <i>HER2</i> Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
Purpose To determine whether (1) immunohistochemical (IHC) HER2 status (ie, 2+ or 3+), (2) degree of fluorescence in situ hybridization (FISH) amplification according to (2a) HE...
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
Single-agent trastuzumab is active and well tolerated as first-line treatment of women with metastatic breast cancer with HER2 3+ overexpression by IHC or gene amplification by ...
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-positive metastatic breast cancer. In addition to nausea and myelosuppressi...
Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm
Purpose: Trastuzumab-based therapy improves survival for women with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. We conducted a multicenter p...
Publication Info
- Year
- 2005
- Type
- article
- Volume
- 93
- Issue
- 1
- Pages
- 3-11
- Citations
- 211
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
211
OpenAlex
Cite This
Noël Dybdal,
Grazyna Leiberman,
Steven M. Anderson
et al.
(2005).
Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab.
Breast Cancer Research and Treatment
, 93
(1)
, 3-11.
https://doi.org/10.1007/s10549-004-6275-8
Identifiers
- DOI
- 10.1007/s10549-004-6275-8